GeoVax Labs (GOVX) vs Silo Pharma (SILO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
GeoVax Labs is the larger company by market cap ($3.0 million vs $2.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | GOVX | SILO |
|---|---|---|
| Share price | $0.30 | $1.37 |
| Market cap | $3.03M | $2.81M |
| 1-day change | +3.74% | -4.86% |
| EPS (TTM) | $-8.84 | $-4.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.75 | $10.44 |
| 52-week low | $0.277 | $1.30 |
| Distance from 52-week high | -98.10% | -86.88% |
| Average volume | 769.87K | 114.43K |
| Shares outstanding | 10.10M | 2.05M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
GOVX vs SILO FAQ
Which is bigger, GeoVax Labs or Silo Pharma?
GeoVax Labs (GOVX) is larger, with a market capitalization of $3.03M compared with $2.81M for Silo Pharma (SILO).
Are GeoVax Labs and Silo Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.